Sunday, November 22, 2026 Washington. Times are Eastern.

Appointments

White House withdraws FDA nominee Heidi Overton ahead of Senate vote

The administration pulled Dr. Heidi Overton's nomination after anti-abortion Republicans sought commitments on life issues the White House would not make, Sen. Bill Cassidy said.

Main entrance of FDA Building 1, housing the Commissioner's offices, at the FDA campus in Silver Spring, Maryland.
The main entrance of FDA Building 1 on the FDA campus in Silver Spring, Maryland. Photograph: The U.S. Food and Drug Administration/Wikimedia Commons (public domain)

The White House announced Tuesday that it has withdrawn Dr. Heidi Overton's nomination to lead the Food and Drug Administration, Federal News Network, ABC7 New York and the Bozeman Daily Chronicle reported.

Overton is a physician who is a White House domestic policy adviser and has spent most of her career working for Trump or aligned conservative groups, Federal News Network reported. Her nomination in August was intended to put a steady Trump loyalist at the FDA after a turbulent year under Dr. Marty Makary, Trump's first FDA commissioner.

In the Senate, Overton drew bipartisan questions about whether she would contradict Trump, particularly on his unproven claims about childhood vaccine risks, Federal News Network and ABC7 New York reported. Senator Bill Cassidy, a Louisiana Republican and physician who chairs the health committee, said earlier Tuesday that he was still undecided before a committee vote expected Wednesday. Cassidy had previously said Overton's support for Trump's proposal to split combination vaccines such as the measles, mumps and rubella shot was "almost disqualifying".

In a Tuesday night post on X, Cassidy said he believed Overton "would have had the votes to pass out of committee and pass the full Senate". He wrote that anti-abortion Republicans had sought commitments from the White House on "life issues," and that "the Administration withdrew Dr. Overton rather than make such commitments".

The FDA is currently reviewing the safety of the abortion pill mifepristone at Trump's request, a step that could restore prescribing restrictions. The agency has said it will issue a safety report by March.

Confirmation required support from all 12 Republican members of the Senate Health, Education, Labor and Pensions Committee, because Democrats hold 11 seats. Without committee approval, her chances in the full Senate were slim. Republicans have been working quickly to confirm Trump's nominees before Democrats take control of the Senate in January.

Overton's nomination also drew opposition from leaders in the Make America Healthy Again movement. Calley Means recently told Joe Rogan that White House aides such as Overton pushed for a Supreme Court ruling that blocked many lawsuits over the weedkiller glyphosate, and that industry lobbyists prompted those actions. Means said a "very concentrated group" in the administration is "antagonistic to what people voted for".

Other health nominees have also been withdrawn: Dr. David Weldon for CDC was replaced over concerns about Republican support, and two picks for surgeon general, including Dr. Casey Means, were pulled amid resistance.

Kyle Diamantas, an attorney who is close to Donald Trump Jr., currently serves as acting FDA commissioner after being promoted from the agency's top food post in May. Federal rules cap acting officials at roughly seven months in charge. During Makary's tenure the FDA saw scientific fights, leadership turnover and low staff morale, and about 20% of its workforce has left through layoffs, buyouts, retirements or resignations since the start of Trump's term.

The White House has not said whether it will put forward another nominee.

Update, November 20, 2026

Senate Health, Education, Labor and Pensions Committee Chairman Bill Cassidy said Tuesday night that he does not intend to rush any FDA nominee through the lame-duck session and that confirming a permanent commissioner will fall to Senate Democrats, States Newsroom reported Friday. His statement came after the White House withdrew Heidi Overton's nomination, which had been scheduled for a committee vote Wednesday. "Unfortunately, with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats," Cassidy wrote. Democrats flipped nine Senate seats this month and will hold a 56-44 majority starting in January, meaning the FDA will operate without a confirmed leader until the next Senate acts.

Sources: Federal News Network, ABC7 New York, Bozeman Daily Chronicle, States Newsroom

Celia Marchetti White House correspondent

Celia Marchetti covers the White House, presidential actions and nominations for West Wing Times. Celia writes from the documents the White House and the Federal Register publish, official statements and published reporting, and links every source.

Corrections. Report an error to corrections@westwingtimes.com. We list substantive corrections on the corrections page.